SPI
16.812,63
PKT
+62,42
PKT
+0,37
%
Werbung
Analysen zu SPI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
04.01.22 | Roche Outperform | Bernstein Research | |
04.01.22 | Roche Neutral | JP Morgan Chase & Co. | |
23.12.21 | Holcim Buy | Goldman Sachs Group Inc. | |
23.12.21 | Holcim Neutral | JP Morgan Chase & Co. | |
23.12.21 | Novartis Buy | Jefferies & Company Inc. | |
23.12.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
22.12.21 | DocMorris Buy | Warburg Research | |
21.12.21 | DocMorris Add | Baader Bank | |
21.12.21 | ams-OSRAM Buy | Kepler Cheuvreux | |
21.12.21 | DocMorris Buy | Jefferies & Company Inc. | |
21.12.21 | DocMorris Buy | Warburg Research | |
21.12.21 | DocMorris Buy | Baader Bank | |
20.12.21 | Novartis Buy | Jefferies & Company Inc. | |
20.12.21 | Novartis Underweight | JP Morgan Chase & Co. | |
20.12.21 | Clariant Equal Weight | Barclays Capital | |
17.12.21 | Holcim Buy | UBS AG | |
17.12.21 | Novartis Sell | Deutsche Bank AG | |
17.12.21 | Clariant Neutral | Goldman Sachs Group Inc. | |
17.12.21 | Givaudan Neutral | Goldman Sachs Group Inc. | |
16.12.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
16.12.21 | Novartis Underweight | JP Morgan Chase & Co. | |
16.12.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
16.12.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
16.12.21 | Novartis Buy | Jefferies & Company Inc. | |
15.12.21 | Roche Neutral | UBS AG | |
15.12.21 | Givaudan Neutral | JP Morgan Chase & Co. | |
15.12.21 | Nestlé Buy | Goldman Sachs Group Inc. | |
14.12.21 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
14.12.21 | Nestlé Overweight | JP Morgan Chase & Co. | |
14.12.21 | UBS Outperform | Credit Suisse Group | |
14.12.21 | UBS Buy | Jefferies & Company Inc. | |
14.12.21 | UBS Outperform | RBC Capital Markets | |
13.12.21 | UBS Buy | Kepler Cheuvreux | |
13.12.21 | Zurich Insurance Overweight | Barclays Capital | |
13.12.21 | Swiss Re Overweight | Barclays Capital | |
13.12.21 | Roche Neutral | Credit Suisse Group | |
13.12.21 | Roche Neutral | JP Morgan Chase & Co. | |
13.12.21 | Novartis Neutral | Credit Suisse Group | |
13.12.21 | Zurich Insurance Overweight | Morgan Stanley | |
10.12.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. |